BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 35010895)

  • 1. Probiotics for Alzheimer's Disease: A Systematic Review.
    Naomi R; Embong H; Othman F; Ghazi HF; Maruthey N; Bahari H
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology and management of Alzheimer's disease: Potential role of gut microbiota modulation with probiotics supplementation.
    Lekchand Dasriya V; Samtiya M; Dhewa T; Puniya M; Kumar S; Ranveer S; Chaudhary V; Vij S; Behare P; Singh N; Aluko RE; Puniya AK
    J Food Biochem; 2022 Jan; 46(1):e14043. PubMed ID: 34927261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease.
    Wang Y; Dykes GA
    CNS Neurol Disord Drug Targets; 2022; 21(1):14-25. PubMed ID: 34365962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALZHEIMER'S DISEASE AND ITS RELATIONSHIP WITH THE MICROBIOTA-GUT-BRAIN AXIS.
    Faulin TDES; Estadella D
    Arq Gastroenterol; 2023; 60(1):144-154. PubMed ID: 37194773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on the Protective Effects of Probiotics against Alzheimer's Disease.
    Mishra V; Yadav D; Solanki KS; Koul B; Song M
    Biology (Basel); 2023 Dec; 13(1):. PubMed ID: 38248439
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tan FHP; Liu G; Lau SA; Jaafar MH; Park YH; Azzam G; Li Y; Liong MT
    Benef Microbes; 2020 Feb; 11(1):79-89. PubMed ID: 32066253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review.
    Aaldijk E; Vermeiren Y
    Ageing Res Rev; 2022 Mar; 75():101556. PubMed ID: 34990844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
    Megur A; Baltriukienė D; Bukelskienė V; Burokas A
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major Depressive Disorder and gut microbiota - Association not causation. A scoping review.
    Łoniewski I; Misera A; Skonieczna-Żydecka K; Kaczmarczyk M; Kaźmierczak-Siedlecka K; Misiak B; Marlicz W; Samochowiec J
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110111. PubMed ID: 32976952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics, gut microbiota, and Alzheimer's disease.
    Angelucci F; Cechova K; Amlerova J; Hort J
    J Neuroinflammation; 2019 May; 16(1):108. PubMed ID: 31118068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and its metabolites in Alzheimer's disease: from pathogenesis to treatment.
    Zou X; Zou G; Zou X; Wang K; Chen Z
    PeerJ; 2024; 12():e17061. PubMed ID: 38495755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.
    Baldi S; Mundula T; Nannini G; Amedei A
    World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions.
    Murray ER; Kemp M; Nguyen TT
    Arch Clin Neuropsychol; 2022 Feb; 37(3):595-607. PubMed ID: 35202456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia.
    Zeng C; Yang P; Cao T; Gu Y; Li N; Zhang B; Xu P; Liu Y; Luo Z; Cai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110097. PubMed ID: 32916223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the endocannabinoid system with microbial interventions to improve gut integrity.
    Jansma J; Brinkman F; van Hemert S; El Aidy S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110169. PubMed ID: 33186639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer's Disease.
    Escobar YH; O'Piela D; Wold LE; Mackos AR
    J Alzheimers Dis; 2022; 87(1):17-31. PubMed ID: 35253750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.